We the talks working to help ensure no patient will forgo treatment because of financial limitations or Biogen status , " said the spokeswoman , Ligia Del Bianco .She said Biogen , like many companies that sell expensive drugs , had set A spokeswoman for Biogen a program to help families navigate insurance approvals and other logistics , and will provide financial assistance .Kenneth Hobby , the president of Cure SMA , a patient advocacy group that invested $ 500 , 000in early academic research that led to the development of Spinraza , said more important than the list price of the drug is whether patients who need it will get it .